Advisory Services Network, LLC Oramed Pharmaceuticals Inc. Transaction History

Advisory Services Network, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$5.88 - $12.03 $2,940 - $6,015	500 New	500 $6,000
Q3 2021 Nov 05, 2021	SELL	$12.13 - $23.82 $6,065 - $11,910	-500 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$8.34 - $14.59 $4,170 - $7,295	500 New	500 $7,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.